Medicinal Products

DESOGESTREL TEVA 75 micrograms

Generic drug of Cerazette
Therapeutic class: Contraception and termination of pregnancy
Active ingredients: [DÃsogestrel, 4519]
laboratory: Teva Sante

Filmstrip
box of 3 pads of 28
All forms

Indication

Oral contraception.

Dosage DESOGESTREL TEVA 75 micrograms compressed film boast of 3 platelets of 28

Oral contraception.

Against indications

Hypersensitivity to the active substance or to any of the excipients.

Pregnancy known or suspected.

At venous thromboembolic accidents.

Pr Presence or antecedent of severe hepatic pathology, as long as the parameters of the hepatic function are not normalized.

Known or suspected tumors sensitive to sexual steroids.

Unexplained genital bleeding.

Side effects Desogestrel Teva 75 to g

50% of the women using the deesogestrel reported bleeding irregularities. As deesogestrel leads to an inhibition of ovulation close to 100%, unlike other progestin-only pills, the irregularity of bleeding is more frequent than with these other pills. In 20-30% of women, bleeding may occur more frequently, whereas in 20% of women bleeding may be less frequent or absent altogether. Vaginal bleeding may also be longer lasting. After a few months of treatment, bleeding tends to be less frequent. Information, tips and a bleeding tracking booklet can help women to better accept them.

The other most commonly reported undesirable effects (frequency> 2.5%) in clinical trials with deesestrel are: acne, mood modification, mastodynia, nausea and weight gain. The undesirable effects mentioned in the table below, were considered by the investigators as having a certain, probable or possible causal link with the treatment. Within each frequency group, the undesirable effects are presented in a decreasing order of gravity.

Very often (≥1 / 10)

Frequent (≥1 / 100 to "<1/10)

Not very frequent (≥1 / 1, 000 to <1/100)

Rare (≥1 / 10, 000 to "<1 / 1, 000)

Very rare (<1 / 10, 000)

Frequency unknown (can not be estimated based on available data).

Class of organ systems

Frequency of undesirable effects

FrÚquent

Few Frequent

Rare

Infections and infestations

Vaginal infections

Psychiatric disorders

Mood modification, decreased libido

Nervous System Affections

CÚphalÚes

Eye disorders

Intolerance with contact lenses

Gastrointestinal disorders

NausÚes

vomiting

Skin and subcutaneous tissue disorders

AcnÚ

AlopÚcie

Rash, hives, erythema gnarly

Disorders of reproductive organs and breast

Mastodynia, irregular bleeding, amÃnnorrhèe

DysmÃnnorrhèe, ovarian cyst

General disorders and administration site-related abnormalities

AsthÚnie

investigations

Weight gain

Breast discharge may occur during the use of the deesogestrel. In rare cases, ectopic pregnancies have been reported (see Warnings and Precautions ).

In women using oral contraceptives (combined) a number of undesirable (serious) effects have been reported. They include: venous thromboembolic disorders, arterial thromboembolic disorders, hormone-dependent tumors (eg liver tumors, breast cancer) and chloasma, some of which are detailed in the Warnings and Precautions section .

Declaration of suspected undesirable effects

The declaration of undesirable effects suspected after authorization of the drug is important. It allows continuous monitoring of the beneficial / risk ratio of the drug. Healthcare professionals declare any suspected adverse effects via the national system of declaration: National Agency for the Safety of Medicines and Health Products (ANSM) and the Network of Regional Pharmacovigilance Centers - Website: www.ansm.sante.fr.

Popular Posts

Category Medicinal Products, Next Article